NO985050D0 - Antistoffer mot interferon <alfa>/<beta>-reseptorer - Google Patents

Antistoffer mot interferon <alfa>/<beta>-reseptorer

Info

Publication number
NO985050D0
NO985050D0 NO985050A NO985050A NO985050D0 NO 985050 D0 NO985050 D0 NO 985050D0 NO 985050 A NO985050 A NO 985050A NO 985050 A NO985050 A NO 985050A NO 985050 D0 NO985050 D0 NO 985050D0
Authority
NO
Norway
Prior art keywords
interferon
antibodies
alfa
receptors
beta
Prior art date
Application number
NO985050A
Other languages
English (en)
Other versions
NO324206B1 (no
NO985050L (no
Inventor
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO985050D0 publication Critical patent/NO985050D0/no
Publication of NO985050L publication Critical patent/NO985050L/no
Publication of NO324206B1 publication Critical patent/NO324206B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
NO19985050A 1996-05-01 1998-10-29 Antistoffer mot interferon alfa-/beta-reseptorer og fremgangsmater for fremstilling og anvendelse derav, samt DNA-molekyl, ekspresjonsvektor, vertscelle, farmasoytisk sammensetning, hybridom og sett. NO324206B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11809696A IL118096A0 (en) 1996-05-01 1996-05-01 Antibodies against interferon alpha/beta receptor
PCT/IL1997/000138 WO1997041229A1 (en) 1996-05-01 1997-04-29 Antibodies against interferon alpha/beta receptor

Publications (3)

Publication Number Publication Date
NO985050D0 true NO985050D0 (no) 1998-10-29
NO985050L NO985050L (no) 1998-12-29
NO324206B1 NO324206B1 (no) 2007-09-10

Family

ID=11068814

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985050A NO324206B1 (no) 1996-05-01 1998-10-29 Antistoffer mot interferon alfa-/beta-reseptorer og fremgangsmater for fremstilling og anvendelse derav, samt DNA-molekyl, ekspresjonsvektor, vertscelle, farmasoytisk sammensetning, hybridom og sett.

Country Status (19)

Country Link
US (1) US6136309A (no)
EP (2) EP0927252B1 (no)
JP (1) JP4308322B2 (no)
KR (2) KR100581798B1 (no)
CN (1) CN1198929C (no)
AT (1) ATE342981T1 (no)
AU (1) AU719995B2 (no)
BR (1) BR9709202A (no)
CA (1) CA2253239C (no)
DE (1) DE69736835T2 (no)
DK (1) DK0927252T3 (no)
EA (1) EA002543B1 (no)
ES (1) ES2274542T3 (no)
HK (1) HK1019339A1 (no)
IL (2) IL118096A0 (no)
NO (1) NO324206B1 (no)
PT (1) PT927252E (no)
UA (1) UA76396C2 (no)
WO (1) WO1997041229A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US6713609B1 (en) 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
US6376067B1 (en) * 1998-12-21 2002-04-23 Mitsubishi Polyester Film, Llc Silicone coated film with back side slip control coating and method of controlling slip of such film
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
ATE502648T1 (de) * 2001-01-09 2011-04-15 Baylor Res Inst Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
AU2007202840B2 (en) * 2001-01-09 2011-07-28 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
ES2313039T3 (es) * 2003-04-23 2009-03-01 Medarex, Inc. Composiciones y procedimientos para la terapia de enfermedad inflamatoria intestinal.
AU2007203559B2 (en) * 2003-04-23 2010-09-02 E. R. Squibb & Sons, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
KR101151477B1 (ko) 2003-12-10 2012-06-22 메다렉스, 인코포레이티드 인터페론 알파 항체 및 그의 용도
CN102603894B (zh) * 2004-06-21 2015-09-30 梅达雷克斯有限责任公司 干扰素α受体1抗体及其用途
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
AU2006213800B2 (en) * 2005-02-10 2012-02-09 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
CA2612378A1 (en) * 2005-06-22 2007-01-04 Genentech, Inc. Methods and compositions for targeting ifnar2
AU2009245792B2 (en) 2008-05-07 2012-11-01 Coimmune, Inc. Humanized antibodies against human interferon-alpha
GB2496794B (en) 2010-07-15 2017-11-01 Iliich Epshtein Oleg Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
DE112011102358T5 (de) 2010-07-15 2013-04-25 Oleg Iliich Epshtein Verfahren zur Erhöhung der Wirkung einer aktivierten-potenzierten Form eines Antikörpers
US11136399B2 (en) * 2016-07-14 2021-10-05 Institute Of Biophysics, Chinese Academy Of Sciences Type I interferon receptor antibody and use thereof
CN115558027B (zh) * 2022-12-05 2023-02-28 北京万泰生物药业股份有限公司 一种核酸酶的单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
IL106591A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
AU7782894A (en) * 1993-09-17 1995-04-03 Laboratoire Europeen De Biotechnologie S.A. Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon

Also Published As

Publication number Publication date
DK0927252T3 (da) 2007-02-05
BR9709202A (pt) 1999-08-10
EP1739177A1 (en) 2007-01-03
NO324206B1 (no) 2007-09-10
CN1220699A (zh) 1999-06-23
CA2253239A1 (en) 1997-11-06
EP0927252B1 (en) 2006-10-18
ATE342981T1 (de) 2006-11-15
CN1198929C (zh) 2005-04-27
CA2253239C (en) 2010-08-10
ES2274542T3 (es) 2007-05-16
WO1997041229A1 (en) 1997-11-06
IL118096A0 (en) 1996-09-12
AU719995B2 (en) 2000-05-18
KR100581798B1 (ko) 2006-05-25
UA76396C2 (en) 2006-08-15
US6136309A (en) 2000-10-24
PT927252E (pt) 2007-01-31
EP0927252A1 (en) 1999-07-07
IL126835A (en) 2007-07-24
AU2402797A (en) 1997-11-19
HK1019339A1 (en) 2000-02-03
DE69736835T2 (de) 2007-11-22
NO985050L (no) 1998-12-29
JP2000509276A (ja) 2000-07-25
EA002543B1 (ru) 2002-06-27
KR20040075105A (ko) 2004-08-26
EA199800968A1 (ru) 1999-04-29
DE69736835D1 (de) 2006-11-30
JP4308322B2 (ja) 2009-08-05
KR20000064953A (ko) 2000-11-06

Similar Documents

Publication Publication Date Title
NO985050L (no) Antistoffer mot interferon &lt;alfa&gt;/&lt;beta&gt;-reseptorer
DE68901785D1 (de) Katalytischer umwandler.
DE69014863D1 (de) Festes Katalysatorbestandteil für Olefinpolymerisation und Katalysator für Olefinpolymerisation.
NO20002527D0 (no) Enkeltkjede bifunksjonelle glykoproteinhormoner
ATE212055T1 (de) Östrogen-rezeptor
DE69103864D1 (de) Schalldämpfer mit Katalysator.
FI910973A0 (fi) Antikropp mot tumornekrosfaktorreseptor.
NL193258B (nl) Keten voor het kiezen van een werkingsmodus.
DE59101907D1 (de) Stromrichtermodul.
TR199800604A3 (tr) Anti-fas antikorlari.
NO20000422D0 (no) Katalysatorer basert på fulven-metallkomplekser
DE69230659D1 (de) Polypeptide, die an die schweren Ketten von IL-2-Rezeptoren binden können
DE69526143D1 (de) Abtrennfreier, spezifischer Bindungsassay mit Anti-Inhibitor-Antikörpern
TR199700278A3 (tr) Ilerletme yastigi olan birlestirici tirtilli palet.
NO890116D0 (no) Monoklonale antistoffer.
DK44288D0 (da) Transportoer, isaer til tunge genstande
ES1038575Y (es) Mesa perfeccionada.
NO971044L (no) Blander, isµr for kohesive partikkelmaterialer
ES1029936Y (es) Mochila de colegial perfeccionada.
NO895022D0 (no) Il-2 reseptorspesifikke chimere antistoffer.
ES1037062Y (es) Mesa de mezclas perfeccionada.
ES1017699Y (es) Plataforma ligera de carga, perfeccionada.
NO892941D0 (no) Monoklonalt antistoff mot den rgd-rettede adhesjonsreseptor paa endotelceller.
ES1036243Y (es) Tarima ensamblable perfeccionada.
IT9067092A1 (it) Convertitore d. c. /d. c.

Legal Events

Date Code Title Description
MK1K Patent expired